Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial
Public ClinicalTrials.gov record NCT07060638. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT07060638
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Samer Gawrieh
- Other
- Enrollment
- 216 participants
Conditions and interventions
Conditions
Interventions
- Acamprosate Drug
- IL-22 Drug
- IL-22 (F-652) Placebo Drug
- Motivational Enhancement Therapy (MET) Behavioral
- Motivational Interviewing (MI) Behavioral
- Prednisone Drug
- Prednisone placebo Drug
- Usual Care Behavioral
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 26, 2026
- Primary completion
- Nov 30, 2029
- Completion
- May 31, 2031
- Last update posted
- May 13, 2026
2026 – 2031
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Indiana University | Indianapolis | Indiana | 46202 | Recruiting |
| University of Louisville | Louisville | Kentucky | 40292 | Recruiting |
| Mayo Clinic | Rochester | Minnesota | 55902 | Recruiting |
| Cleveland Clinic | Cleveland | Ohio | 44195 | Recruiting |
| University of Texas Southwestern Medical School | Dallas | Texas | 15260 | Recruiting |
| Virginia Commonwealth University | Richmond | Virginia | 23284 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07060638, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07060638 live on ClinicalTrials.gov.